L S Chutko Selected Research

mebikar

1/2014	[Asthenic disorders in children and their differentiated treatment].
1/2013	[Psychoautonomic disorders in patients with hypertension, stage I and possibilities of their treatment].
1/2012	[Generalized anxiety disorder: psychosomatic aspects and treatment approaches].
1/2012	[Chronic tic disorders in children and adolescents and their treatment with adaptol].
1/2011	[Adaptol in the treatment of chronic cervicogenic headache].
1/2011	[The use of adaptol in the treatment of the autonomic dystonia syndrome in children].
1/2010	[Asthenic disorders in children].
1/2010	[Adaptol in the treatment of anxiety disorders in children with school maladaptation].
1/2009	[The use of adaptol in the treatment of tick hyperkinesis is children].
1/2009	[Adaptol in the treatment of ADHD].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

L S Chutko Research Topics

Disease

7	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2018 - 01/2008
4	Cognitive Dysfunction 01/2019 - 01/2013
4	Neurasthenia 01/2014 - 01/2006
3	Anxiety Disorders (Anxiety Disorder) 01/2012 - 01/2009
2	Asthenia 01/2021 - 01/2014
2	Headache (Headaches) 01/2021 - 01/2010
2	Tics (Tic) 01/2019 - 01/2006
2	Hyperkinesis 01/2009 - 01/2006
1	Fatigue 01/2021
1	Conversion Disorder (Astasia Abasia) 01/2021
1	Dyslexia (Alexia) 01/2021
1	Adjustment Disorders (Adjustment Disorder) 01/2021
1	Tension-Type Headache (Tension Headache) 01/2019
1	Enuresis 01/2018
1	Somatoform Disorders (Somatoform Disorder) 01/2017
1	Autistic Disorder (Autism) 01/2017
1	Autism Spectrum Disorder 01/2017
1	Migraine Disorders (Migraine) 01/2017
1	Specific Language Disorder 01/2015
1	Sensorineural Hearing Loss 01/2015
1	Essential Hypertension 01/2013
1	Tic Disorders (Tic Disorder) 01/2012
1	Post-Traumatic Headache 01/2011
1	Dystonia (Limb Dystonia) 01/2011
1	Memory Disorders (Memory Loss) 01/2011

Drug/Important Bio-Agent (IBA)

10	mebikarIBA 01/2014 - 01/2009
7	cerebrolysinIBA 01/2018 - 01/2013
4	cortexinIBA 01/2021 - 01/2006
3	cytoflavinIBA 01/2021 - 01/2017
2	Indicators and Reagents (Reagents)IBA 01/2021 - 01/2017
2	4-amino-3-phenylbutyric acid (phenibut)IBA 01/2017 - 01/2016
1	antineoplaston A10 (A 10)IBA 01/2021
1	Neuroprotective AgentsIBA 01/2015
1	N 30IBA 01/2014
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2014
1	Nootropic Agents (Nootropics)IBA 01/2014
1	Pyrithioxin (Pyritinol)IBA 01/2011
1	BenzodiazepinesIBA 01/2009
1	ethyl phenylacetyl-Pro-GlyIBA 01/2008
1	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 01/2008
1	Hydroxyzine (Vistaril)FDA LinkGeneric 01/2006

Therapy/Procedure

7	Therapeutics 01/2021 - 01/2008
1	Cochlear Implantation 01/2015
1	Aftercare (After-Treatment) 01/2008